Assessing Personalized Medicines in Australia

@inproceedings{Merlin2013AssessingPM,
  title={Assessing Personalized Medicines in Australia},
  author={Tracy Merlin and Claude Farah and Camille Schubert and Andrew Mitchell and Janet Esther Hiller and Philip Ryan},
  booktitle={Medical decision making : an international journal of the Society for Medical Decision Making},
  year={2013}
}
BACKGROUND Since the mapping of the human genome in 2003, the development of biomarker targeted therapy and clinical adoption of "personalized medicine" has accelerated. Models for insurance subsidy of biomarker/test/drug packages ("codependent technologies" or technologies that work better together) are not well developed. Our aim was to create a framework to assess the safety, effectiveness, and cost-effectiveness of these technologies for a national coverage or reimbursement decision… CONTINUE READING